BUSINESS News 23andMe Lays Off 40% of Staff, Shuts Drug Development Business HS 11/11/2024 Advertisements The genetics company is closing a unit that was once seen as core to its future. Source link Continue Reading Previous Aristocrat to Sell Palarium Mobile Gaming for Up to $820 MillionNext Exxon Says Trump Should Keep U.S. in Paris Climate Pact More Stories BUSINESS News Boohoo Changes Chairman as Frasers Calls For Removal HS 21/11/2024 BUSINESS News Archegos Founder Bill Hwang Sentenced to 18 Years in Prison HS 20/11/2024 BUSINESS News Financial Services Roundup: Market Talk HS 20/11/2024